TRRAP and the maintenance of stemness in gliomas

Nikki A Charles1, Eric C Holland

  • 1Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

Cell Stem Cell
|January 21, 2010
PubMed

Insights

Brain tumor recurrence is linked to stem-like cells. A study identified TRRAP as crucial for maintaining glioma stem cell characteristics, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Molecular Biology

Background:

  • Brain tumors, particularly gliomas, exhibit resistance to therapy.
  • Tumor recurrence is often driven by a subpopulation of cancer stem cells.
  • Identifying molecular targets regulating cancer stem cell properties is critical for developing effective treatments.

Purpose of the Study:

  • To identify novel molecular targets involved in maintaining the stem cell character of gliomas.
  • To investigate the role of specific proteins in glioma stem cell self-renewal and tumorigenicity.

Main Methods:

  • A high-throughput kinome-wide screen was employed to identify proteins essential for stem cell character.
  • Functional assays were performed to validate the role of the identified protein in glioma stem cells.

Main Results:

  • The study identified TRRAP (Transformation/transcription activator במהלך protein) as a key regulator of glioma stem cell properties.
  • TRRAP was found to be required for maintaining the stem cell character in gliomas, suggesting its importance in tumor progression and recurrence.

Conclusions:

  • TRRAP is a critical protein for maintaining glioma stem cell identity.
  • Targeting TRRAP may represent a novel therapeutic strategy to overcome therapy resistance and prevent recurrence in gliomas.